Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1176649.RATduWA83NNdRmoyLs0kDykSnw6z4Gk8oREgj4Y83sjUQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1176649.RATduWA83NNdRmoyLs0kDykSnw6z4Gk8oREgj4Y83sjUQ130_assertion type Assertion NP1176649.RATduWA83NNdRmoyLs0kDykSnw6z4Gk8oREgj4Y83sjUQ130_head.
- NP1176649.RATduWA83NNdRmoyLs0kDykSnw6z4Gk8oREgj4Y83sjUQ130_assertion wasGeneratedBy ECO_0000203 NP1176649.RATduWA83NNdRmoyLs0kDykSnw6z4Gk8oREgj4Y83sjUQ130_provenance.
- NP1176649.RATduWA83NNdRmoyLs0kDykSnw6z4Gk8oREgj4Y83sjUQ130_assertion wasDerivedFrom befree-2016 NP1176649.RATduWA83NNdRmoyLs0kDykSnw6z4Gk8oREgj4Y83sjUQ130_provenance.
- NP1176649.RATduWA83NNdRmoyLs0kDykSnw6z4Gk8oREgj4Y83sjUQ130_assertion SIO_000772 24766074 NP1176649.RATduWA83NNdRmoyLs0kDykSnw6z4Gk8oREgj4Y83sjUQ130_provenance.
- NP1176649.RATduWA83NNdRmoyLs0kDykSnw6z4Gk8oREgj4Y83sjUQ130_assertion evidence source_evidence_literature NP1176649.RATduWA83NNdRmoyLs0kDykSnw6z4Gk8oREgj4Y83sjUQ130_provenance.
- NP1176649.RATduWA83NNdRmoyLs0kDykSnw6z4Gk8oREgj4Y83sjUQ130_assertion description "[Two of these compounds, vemurafenib and dabrafenib, have been licensed for the treatment of BRAF-mutant advanced melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1176649.RATduWA83NNdRmoyLs0kDykSnw6z4Gk8oREgj4Y83sjUQ130_provenance.